A new strategy of continuation pharmacotherapy [sertraline] in the prevention of relapse following electroconvulsive therapy: a controlled trial

Trial Profile

A new strategy of continuation pharmacotherapy [sertraline] in the prevention of relapse following electroconvulsive therapy: a controlled trial

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2010

At a glance

  • Drugs Sertraline (Primary)
  • Indications Depression; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Sep 2008 Results presented at ECNP
    • 06 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top